The strategy for the management of type 2 diabetes was updated in 2018 in response to the abundance of new cardiovascular outcome data from the CVOTs published since 2015, which showed safety, tolerability, and cardiovascular and renoprotection with 2 classes of agents, sodium glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide receptor agonists (GLP1RA) in patients with established CVD (11)
Comprehensive Solution - Perfect for those seeking fat burners, weight loss supplements, appetite suppressants, or metabolism boosters to achieve their fitness goals.
GLP-1s May Lower Cancer Risk Through Numerous Pathways A big question is whether any GLP-1 anticancer benefit comes mainly from weight loss, or whether these drugs may also have effects that go beyond weight loss itself
McGuinness, G., & Kim, Y
The study has found that mold exposure and mold hypersensitivity syndrome may be risk factors for POTS, chronic fatigue syndrome, and complex regional pain syndrome (CRPS) (11)
4 mg of retatrutide is 40 units at a 10 mg/mL concentration, or 80 units at 5 mg/mL
